167 related articles for article (PubMed ID: 30009879)
41. Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia.
Kaur V; Mehta P; Johnsurd J; Govindarajan R
Blood; 2014 Nov; 124(23):3503-5. PubMed ID: 25431479
[No Abstract] [Full Text] [Related]
42. Ibrutinib for Chronic Lymphocytic Leukemia.
Ruchlemer R; Ben Ami R; Lachish T
N Engl J Med; 2016 Apr; 374(16):1593-4. PubMed ID: 27096597
[No Abstract] [Full Text] [Related]
43. Ibrutinib for Chronic Lymphocytic Leukemia.
Rigolin GM; Cavazzini F; Cuneo A
N Engl J Med; 2016 Apr; 374(16):1593. PubMed ID: 27096596
[No Abstract] [Full Text] [Related]
44. Ibrutinib for Chronic Lymphocytic Leukemia.
Sharman JP; Mato AR; Keating MJ
N Engl J Med; 2016 Apr; 374(16):1592-3. PubMed ID: 27096595
[No Abstract] [Full Text] [Related]
45. Ibrutinib for Chronic Lymphocytic Leukemia.
Burger JA; Styles L; Kipps TJ
N Engl J Med; 2016 Apr; 374(16):1594-5. PubMed ID: 27096594
[No Abstract] [Full Text] [Related]
46. Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib.
Boudin L; Patient M; Tsitsi Nding Tsogou P; Roméo E; Bladé JS; de Jauréguiberry JP
Bull Cancer; 2019 Jan; 106(1):84-85. PubMed ID: 30579570
[No Abstract] [Full Text] [Related]
47. Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia.
Mato AR; Islam P; Daniel C; Strelec L; Kaye AH; Brooks S; Ganetsky A; Nasta S; Porter DL; Svoboda J; Nabhan C; Schuster SJ
Blood; 2016 Feb; 127(8):1064-7. PubMed ID: 26702066
[No Abstract] [Full Text] [Related]
48. Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia.
Roeker LE; Sarraf Yazdy M; Rhodes J; Goodfriend J; Narkhede M; Carver J; Mato A
JAMA Netw Open; 2019 Dec; 2(12):e1916326. PubMed ID: 31790561
[TBL] [Abstract][Full Text] [Related]
49. Cardiovascular Side Effects of Tyrosine Kinase Inhibitor Ibrutinib (Imbruvica) and Interaction With Direct Oral Anticoagulant.
Khalid M; Khattak F; Ramu V
Am J Ther; 2018; 25(6):e768-e769. PubMed ID: 29916856
[No Abstract] [Full Text] [Related]
50. Ibrutinib in relapsed chronic lymphocytic leukemia.
Neffendorf JE; Gout I; Hildebrand GD
N Engl J Med; 2013 Sep; 369(13):1277. PubMed ID: 24066759
[No Abstract] [Full Text] [Related]
51. Ibrutinib in relapsed chronic lymphocytic leukemia.
Byrd JC; O'Brien S; James DF
N Engl J Med; 2013 Sep; 369(13):1278-9. PubMed ID: 24066758
[No Abstract] [Full Text] [Related]
52. Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.
Kipps TJ; Fraser G; Coutre SE; Brown JR; Barrientos JC; Barr PM; Byrd JC; O'Brien SM; Dilhuydy MS; Hillmen P; Jaeger U; Moreno C; Cramer P; Stilgenbauer S; Chanan-Khan AA; Mahler M; Salman M; Eckert K; Solman IG; Balasubramanian S; Cheng M; Londhe A; Ninomoto J; Howes A; James DF; Hallek M
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):715-722.e6. PubMed ID: 31447270
[TBL] [Abstract][Full Text] [Related]
53. Ibrutinib and Pyoderma Gangrenosum in a Patient With B-Cell Chronic Lymphocytic Leukemia.
Giovanni B; Ibatici A; Sola S; Brunasso AMG; Massone C
Am J Dermatopathol; 2020 Feb; 42(2):148-150. PubMed ID: 30839345
[No Abstract] [Full Text] [Related]
54. Cost-Effectiveness of Ibrutinib Compared With Obinutuzumab With Chlorambucil in Untreated Chronic Lymphocytic Leukemia Patients With Comorbidities in the United Kingdom.
Sinha R; Redekop WK
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e131-e142. PubMed ID: 29398648
[TBL] [Abstract][Full Text] [Related]
55. Ibrutinib for the treatment of chronic lymphocytic leukemia.
Deodato M; Frustaci AM; Zamprogna G; Cairoli R; Montillo M; Tedeschi A
Expert Rev Hematol; 2019 May; 12(5):273-284. PubMed ID: 30916599
[TBL] [Abstract][Full Text] [Related]
56. Analysis of Efficacy and Tolerability of Bruton Tyrosine Kinase Inhibitor Ibrutinib in Various B-cell Malignancies in the General Community: A Single-center Experience.
Ali N; Malik F; Jafri SIM; Naglak M; Sundermeyer M; Pickens PV
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S53-S61. PubMed ID: 28760303
[TBL] [Abstract][Full Text] [Related]
57. Chronic lymphocytic leukemia in a patient with well-controlled HIV infection: successful treatment with ibrutinib.
England JT; Leitch HA
Leuk Lymphoma; 2018 Mar; 59(3):752-754. PubMed ID: 28728450
[No Abstract] [Full Text] [Related]
58. Invasive aspergillosis with pulmonary and central nervous system involvement during ibrutinib therapy for relapsed chronic lymphocytic leukaemia: case report.
Peri AM; Bisi L; Cappelletti A; Colella E; Verga L; Borella C; Foresti S; Migliorino GM; Gori A; Bandera A
Clin Microbiol Infect; 2018 Jul; 24(7):785-786. PubMed ID: 29427802
[No Abstract] [Full Text] [Related]
59. Zanubrutinib in B-cell malignancies.
Das M
Lancet Oncol; 2019 Sep; 20(9):e470. PubMed ID: 31378456
[No Abstract] [Full Text] [Related]
60. Ibrutinib increased survival more than chlorambucil in older patients with untreated chronic lymphocytic leukemia.
Aronson FR
Ann Intern Med; 2016 Apr; 164(8):JC44. PubMed ID: 27089094
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
